EX-2.1
from 8-K
138 pages
Agreement and Plan of Merger Among: Idera Pharmaceuticals, Inc., a Delaware Corporation; Bell Merger Sub I, Inc., a Delaware Corporation; Bell Merger Sub II, LLC, a Delaware Limited Liability Company; and Aceragen, Inc., a Delaware Corporation Dated as of September 28, 2022
12/34/56
EX-2.1
from 425
128 pages
Agreement and Plan of Merger Among Biocryst Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc., Nautilus Holdco, Inc., Island Merger Sub, Inc. and Boat Merger Sub, Inc. Dated as of January 21, 2018
12/34/56
EX-2.1
from 425
128 pages
Agreement and Plan of Merger Among Biocryst Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc., Nautilus Holdco, Inc., Island Merger Sub, Inc. and Boat Merger Sub, Inc. Dated as of January 21, 2018
12/34/56
EX-2.1
from 8-K
128 pages
Agreement and Plan of Merger Among Biocryst Pharmaceuticals, Inc., Idera Pharmaceuticals, Inc., Nautilus Holdco, Inc., Island Merger Sub, Inc. and Boat Merger Sub, Inc. Dated as of January 21, 2018
12/34/56